[1] 迟家敏.实用糖尿病学[M].北京:人民卫生出版社,2009.
[2] 顾卫琼.造血干细胞移植治疗1型糖尿病[J].内科理论与实践, 2011,6(4):275-278.
[3] 季代金,黄茂涛, 王维萍.干细胞研究与糖尿病治疗的研究进展[J].中国全科医学, 2011,14(5):569-571.
[4] 吴梅青,易正山,黄芬,等.含或不含全身照射的预处理方案对急性白血病allo-HSCT疗效的影响[J].中华器官移植杂志,2012, 32(2):77-81.
[5] 施红,顾惜春,朱玲,等.联合化疗加重组人粒细胞集落刺激因子动员自体外周血干细胞[J].中华肿瘤杂志,2001, 23(2):159-161.
[6] Schnitzler M, Hasskarl J, Egger M,et al. Successful treatment of severe acute intestinal graft-versus-host resistant to systemic and topical steroids with alemtuzumab.Biol Blood Marrow Transplant. 2009;15(8):910-918.
[7] Andree H, Hilgendorf I, Leithaeuser M,et al. Enteral budesonide in treatment for mild and moderate gastrointestinal chronic GVHD.Bone Marrow Transplant. 2008;42(8):541-546.
[8] Villanueva FN, Pérez-Simón JA, Silva FF,et al.Oral beclomethasone dipropionate for the treatment of gastrointestinal chronic graft-versus-host disease.Biol Blood Marrow Transplant. 2009;15(10):1331-1336.
[9] 蓝梅,高清平.异基因外周血干细胞移植治疗白血病的临床观察[J].内科危急重症杂志,2012,18(4):221-223.
[10] 乔淑敏,王易,胡绍燕.异基因造血干细胞移植治疗儿童重型再生障碍性贫血[J].实用儿科临床杂志,2012, 27(15):1167-1169.
[11] 彭俏,贺德志,李建生.肝小静脉闭塞病的临床现状及研究进展[J].世界华人消化杂志,2012,20(12):1030-1035.
[12] Becze E.Veno-occlusive disease is the most common hepatic complication in stem cell transplants.ONS Connect. 2012; 27(11):16-17.
[13] 冯凯,许怡薇,叶扶光,等.自体外周血造血干细胞移植治疗1型糖尿病的临床观察[J].中华医学杂志,2011,91(28):1966-1969.
[14] 冯凯,许怡薇,叶扶光,等.自体骨髓移植治疗儿童1型糖尿病[J].军医进修学院学报,2012,33(1):16-18.
[15] 王椿.提高血液科医生抗感染水平任重道远[J].中华血液学杂志, 2012, 33(8):603-604.
[16] Demiraslan H, Sevim M, Pala C,et al. Risk factors influencing mortality related to Stenotrophomonas maltophilia infection in hematology-oncology patients. Int J Hematol. 2013;97(3): 414-420.
|